Systemic sclerosis (scleroderma): open trials in Australia

• NCT07778446

  A Study to Test CRT-402 in Refractory Autoimmune Disease

  Trial Treatment · Phase 1/2 · Myeloid Therapeutics

  Linear Advanced Clinical Trial Centre, Ground Floor, B Block, Queen Elizabeth II Medical Centre, Hospital Avenue, Nedlands

  Registry updated 2026-10-22

• NCT07641634

  A Phase 1/2 Study of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis.

  Trial Treatment · Phase 1/2 · Prolium Bioscience, Inc

  Nucleus Network, Melbourne

  Registry updated 2026-10-09

• NCT05878717

  A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

  Trial Treatment · Phase 2/3 · GlaxoSmithKline

  Adelaide · Camperdown · Fitzroy · Liverpool · Woodville South

  Registry updated 2026-09-08

• NCT07284797

  A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases

  Trial Treatment · Phase 1 · Xencor, Inc.

  Melbourne

  Registry updated 2026-08-03

• NCT07115745

  A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

  Trial Treatment · Phase 1 · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

  Brisbane · Camperdown · Clayton

  Registry updated 2026-07-14

All Systemic sclerosis (scleroderma) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error